Related Experiment Video
Updated: Mar 13, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Management of malignant pleural mesothelioma
1Department of Radiation Oncology, Trabzon Numune Education and Research Hospital, Trabzon, Turkey.
Abstract:
Malignant pleural mesothelioma is a rare neoplasm arising from the surface serosal cells of the pleural cavity. More than 80% of cases of malignant pleural mesothelioma have been attributed to asbestos exposure. In its natural course median survival is 4 to 12 months. If untreated most of patients die due to local complications of the disease. Surgery improves local control but is not sufficient as a single treatment modality. The recommended treatment strategy for a select group of patients is multimodal therapy that includes surgery, radiotherapy and chemotherapy.
Insights
Malignant pleural mesothelioma, a rare cancer linked to asbestos, has a poor prognosis. Multimodal therapy combining surgery, radiotherapy, and chemotherapy offers improved local control for select patients.
Area of Science:
- Oncology
- Pleural Diseases
- Asbestos-Related Illnesses
Background:
- Malignant pleural mesothelioma is a rare cancer originating in the pleural cavity's serosal cells.
- Asbestos exposure is the primary cause, linked to over 80% of cases.
- The disease has a median survival of 4-12 months and often leads to fatal local complications if untreated.
Approach:
- This abstract outlines the standard treatment approaches for malignant pleural mesothelioma.
- It highlights the limitations of single-modality treatments.
- It emphasizes the necessity of multimodal therapy for optimal patient outcomes.
Key Points:
- Surgery alone is insufficient for treating malignant pleural mesothelioma.
- Multimodal therapy, integrating surgery, radiotherapy, and chemotherapy, is the recommended strategy.
- This approach aims to improve local disease control and patient survival.
Conclusions:
- Malignant pleural mesothelioma requires aggressive, combined treatment strategies.
- Multimodal therapy offers the best chance for managing this rare and aggressive cancer.
- Further research into optimizing multimodal treatment protocols is warranted.
Related Concept Videos
Pleural Disorders: Types and Brief Description
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pulmonary Embolism III: Nursing Management
Pneumothorax-II
Clinical Manifestations:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pleura of the Lungs

